Navigation Links
Epitomics, Inc. Receives Notice of Allowance from the United States Patent and Trademark Office for a Novel Method for Identifying Differentially Expressed Proteins
Date:11/1/2011

BURLINGAME, Calif., Nov. 1, 2011 /PRNewswire/ -- Epitomics, Inc., a California based biotech company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office for its Method for Identifying Differentially Expressed Proteins (application 10/705,109).  The Notice allowed 17 claims for detection of differentially expressed proteins in cell samples using libraries of antibodies.  This method has several potentially broad applications in the research and drug discovery markets, especially in the field of cancer.

"We are very excited to be granted the claims of this novel method," stated Dr. Guo-Liang Yu, Chief Executive Officer. "This is another step towards building a world class intellectual property estate around our unique and proprietary rabbit monoclonal  technology.  We look forward to continued success in the development of our technology and patents, and ultimately to providing the best antibodies and solutions to researchers and clinicians." 

About Epitomics

Epitomics, Inc., an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research and diagnostic applications. The company utilizes a unique and proprietary RabMAb® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity, specificity and bioactivity both in vitro and in vivo. Epitomics, Inc. is headquartered in Burlingame, California, and operates wholly owned subsidiaries in Hong Kong and Hangzhou, the People's Republic of China. For more information about Epitomics, please visit www.epitomics.com


'/>"/>
SOURCE Epitomics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation
2. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
3. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
4. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
5. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
6. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
7. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
8. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
9. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
10. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
11. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... Pono Ola , a mind-body ... lifestyle, announced today the official launch of its much-anticipated Pono Board: a re-invented fitness ... , In development for over a year, the patented Pono Board is the world’s ...
(Date:1/17/2017)... , Jan. 17, 2017  On January 10 at ... Annual J.P. Morgan Healthcare Conference in San ... Kittle, Jr. , spoke to pharmaceutical leaders and public ... ProclaRx to break down and destroy biofilms.  ... and prevent antibiotics and the body,s immune system from ...
(Date:1/14/2017)... ... January 14, 2017 , ... ... service providing complete end-to-end genome assemblies to researchers around the globe. Long ... major obstacle in answering a wide range of scientific questions. The announcement ...
(Date:1/13/2017)... Island, NY (PRWEB) , ... January 13, 2017 ... ... to meet every cuvette-related demand that it has found among its diverse customer ... cuvettes for use in most brands electroporators including BTX and Bio-Rad. FireflySci ...
Breaking Biology Technology:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL ... desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar ... 2017, con múltiples sitios previstos a lo largo de Europa y ... MSC-1 es ... inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ...
(Date:12/16/2016)... The global wearable medical device market, in terms of ... USD 5.31 billion in 2016, at a CAGR of 18.0% during ... ... in medical devices, launch of a growing number of smartphone-based healthcare ... healthcare providers, and increasing focus on physical fitness. ...
(Date:12/15/2016)... -- ... Research and Markets has announced the addition of the "Global Military ... report forecasts the global military biometrics market to grow at a CAGR ... been prepared based on an in-depth market analysis with inputs from industry ... the coming years. The report also includes a discussion of the key ...
Breaking Biology News(10 mins):